Albanese says PBS ‘not up for negotiation’ after US pharma complains to Trump about scheme

Labor and Coalition shoot back at criticism, with the PM saying subsidies on medicine ‘isn’t about delivering for big pharma’

Follow our Australia news live blog for latest updatesGet our breaking news email, free app or daily news podcast

Australia’s successful scheme for heavily subsidising the price of vital medicines is “not up for negotiation” as part of new American tariff threats, Anthony Albanese says, after US pharmaceutical companies complained to Donald Trump about how it damaged their profits.

Labor and the Coalition have both shot back at criticism of the Pharmaceutical Benefits Scheme from America’s pharmaceutical industry, after the government announced – and the opposition quickly matched – plans to publicly subsidise medicines even further.

Sign up for Guardian Australia’s breaking news email

Continue reading…

About Author